Influence of Different Spacer Arms On Mimetic LigandTM A2P and B14 Membranes for Human IgG Purification

Thursday, October 20, 2011: 3:55 PM
M100 I (Minneapolis Convention Center)
Cristiana Boi1, Simone Dimartino1, Stefan Hofer2, Jeannie Horak2, Sharon Williams3, Giulio C. Sarti1 and Wolfgang Lindner2, (1)University of Bologna, Bologna, Italy, (2)Department of Analytical Chemistry, University of Vienna, Vienna, Austria, (3)ProMetic Biosciences Ltd, Cambridge, United Kingdom

Microporous membranes are an attractive alternative to circumvent the typical drawbacks associated to bead-based chromatography.

In particular, the present work intends to evaluate different affinity membranes for antibody capture, to be used as an alternative to Protein A resins. To this aim, two Mimetic LigandsTM A2P and B14, were coupled onto different epoxide and azide group activated membrane supports using different spacer arms and immobilization chemistries. These new mimetic membrane materials were investigated by static and by dynamic binding capacity studies, using pure polyclonal human immunoglobulin G (IgG) solutions. Complete chromatographic cycles were also performed using a real cell culture supernatant containing monoclonal IgG1. The best results were obtained by combining the new B14 ligand with a TRZ-spacer and an improved Epoxy 2 membrane support material. The new B14-TRZ-Epoxy2 membrane adsorbent provided binding capacities of approximately 3.1 mg/mL, besides (i) a good selectivity towards IgG, (ii) high IgG recoveries of above 90%, (iii) a high Pluronic-F68 tolerance and (iv) noB14-ligand leakage under harsh cleaning-in-place conditions (0.6M sodium hydroxide). Furthermore, foreseeable improvements in binding capacity will promote the implementation of membrane adsorbers in antibody manufacturing.


Extended Abstract: File Not Uploaded
See more of this Session: Bioseparations and Downstream Processing
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division